Related Experiment Videos
Robust two-stage estimation in hierarchical nonlinear models.
1Department of Medicine, Harvard Medical School and Massachusetts General Hospital, Boston 02114-2696, USA. yeap@newton.mgh.harvard.edu
Biometrics
|March 17, 2001
Summary
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Adverse events associated with sequential immune checkpoint inhibitor and alectinib in patients with ALK-rearranged advanced non-small-cell lung cancer.
ESMO open·2025
Same author
Chemotherapy and programmed cell death protein 1/programmed death-ligand 1 inhibitor combinations for tyrosine kinase inhibitor-resistant, epidermal growth factor receptor-mutated non-small-cell lung cancer: a meta-analysis.
ESMO open·2024
Same author
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author
Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author
A Placebo-Controlled, Prospective, Randomized Clinical Trial of Polyethylene Glycol and Methylprednisolone Sodium Succinate in Dogs with Intervertebral Disk Herniation.
Journal of veterinary internal medicine·2015
Same author
Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same journal
Fast penalized generalized estimating equations for large longitudinal functional datasets.
Biometrics·2026
Same journal
Statistical inference for mean function of partially observed functional time series.
Biometrics·2026
Same journal
Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.
Biometrics·2026